Interested in working at OHSU Knight Cancer Institute? We have a billion reasons!

OHSU is a nationally recognized health and research university. We bring together patient care, research, education of the next generation of health care providers and scientists and community service to improve the health and well-being of all Oregonians and people around the world. The Knight Cancer Institute at OHSU is an international leader in cancer research and precision treatment. Our director, Brian Druker, M.D., helped usher in the era of precision cancer medicine with research that led to the breakthrough drug Gleevec®. 

• The institute is the only National Cancer Institute (NCI)-designated Cancer Center between Sacramento and Seattle —an honor earned only by the nation's top cancer centers.
• It is also the headquarters for the NCI's SWOG collaborative, a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine.

The Knight Cancer Institute has attracted both public support and private philanthropy to build upon its scientific and clinical leadership. The OHSU Knight Cancer Institute met the $1 billion Knight Cancer Challenge, issued in by Phil and Penny Knight, to advance research to fight cancer at its earliest stages and detect the disease before it spreads.

The Knight Cancer Institute is fast-tracking the recruitment of 250 to 300 scientists and physician investigators — led by two dozen or more of the world's top cancer researchers — to unite behind a single, powerful vision to transform cancer care.

Check out the job openings at the OHSU Knight Cancer Institute. Join our mission to end the burden of cancer as we know it.